Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Romettino

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|July 9, 1991
Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsyS Romettino, M Lazdunski, C Gottesmann
Physiology & Behavior|January 1, 1990
Genetically epileptic rats show a pronounced intermediate stage of sleepG Gandolfo, S Romettino, C Gottesmann, et al.
European Journal of Pharmacology|August 11, 1989
K+ channel openers decrease seizures in genetically epileptic ratsG Gandolfo, S Romettino, C Gottesmann, et al.
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|July 9, 1991
Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsyS Romettino, M Lazdunski, C Gottesmann
Physiology & Behavior|January 1, 1990
Genetically epileptic rats show a pronounced intermediate stage of sleepG Gandolfo, S Romettino, C Gottesmann, et al.
European Journal of Pharmacology|August 11, 1989
K+ channel openers decrease seizures in genetically epileptic ratsG Gandolfo, S Romettino, C Gottesmann, et al.
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Pageof 1